A retrospective study evaluating encorafenib-cetuximab +/- binimetinib in BRAF V600E-mutated colorectal cancer
Latest Information Update: 16 Jul 2022
At a glance
- Drugs Binimetinib (Primary) ; Cetuximab (Primary) ; Encorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 16 Jul 2022 New trial record
- 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology